Select for export From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/prp2.70097 Copy citation Copy BibTeX PsyArXiv 2024-09-30 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionPTSDRandomized Controlled Trial Randomized Controlled Trial More
Select for export Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-024-03103-7 PubMed 39349428 Copy citation Copy BibTeX Translational Psychiatry 2024-09-29 Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy OpenAlex Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement Abstract available at the source but not redistributed here. Read at source. Details DOI 10.36348/merjbs.2024.v04i05.001 Copy citation Copy BibTeX Middle East Research Journal of Biological Sciences 2024-09-27 Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Review Article More
Select for export Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.09.133 PubMed 39343309 Copy citation Copy BibTeX Journal of Affective Disorders 2024-09-26 Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial More
Select for export Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-4492873/v1 Copy citation Copy BibTeX Research Square 2024-09-25 Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-09-24 University of California, San Francisco ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionHealthcare WorkersSafety Other More
Select for export Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.09.23.614626 Copy citation Copy BibTeX bioRxiv 2024-09-23 Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionAnxietyEnd-of-Life Distress Animal Study More
Select for export Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp024r.0028 PubMed 40458078 Copy citation Copy BibTeX Psychedelics. 2024-09-23 Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez OpenAlex Published psilocybin DepressionBrain ImagingReceptor Pharmacology Other More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.09.19.24313958 Copy citation Copy BibTeX medRxiv 2024-09-21 Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionBrain ImagingReceptor Pharmacology Other More
Select for export Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241278873 PubMed 39302087 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-09-19 Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, Friederike Holze, Gregor Hasler OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-09-18 University Hospital, Ghent ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyBrain Imaging Clinical Trial More
Select for export Psychedelic research at a crossroads. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1126/science.adt1024 PubMed 39298596 Copy citation Copy BibTeX Unknown journal 2024-09-18 Armstrong SB, Davis AK. Europe PMC Published psilocybin DepressionPTSDConsciousness Clinical Trial More
Select for export Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials Abstract available at the source but not redistributed here. Read at source. Details DOI 10.19080/jcmah.2024.13.555852 Copy citation Copy BibTeX Journal of Complementary Medicine & Alternative Healthcare 2024-09-16 Danielle B Rodrigues OpenAlex Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export Exploring the regulatory framework of psychedelics in the US & Europe. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2024.104242 Copy citation Copy BibTeX Unknown journal 2024-09-16 Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export New frontiers in the biosynthesis of psychoactive specialized metabolites. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbi.2024.102626 PubMed 39288539 Copy citation Copy BibTeX Unknown journal 2024-09-15 Li G, Facchini PJ. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp024r.0025 Copy citation Copy BibTeX Psychedelics. 2024-09-12 Syed F. Rab, Charles L. Raison, Elliot Marseille OpenAlex Published psilocybin DepressionAddictionTreatment-Resistant Depression Other More
Select for export Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/14651858.cd015383.pub2 PubMed 39260823 Copy citation Copy BibTeX Unknown journal 2024-09-11 Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psychoactive substances for the treatment of neuropsychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2024.104193 PubMed 39243659 Copy citation Copy BibTeX Unknown journal 2024-09-02 Zhen Z, Sun X, Yuan S, Zhang J. Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/rapm-2024-esra.582 Copy citation Copy BibTeX Unknown journal 2024-08-31 Amany E. Ayad OpenAlex Published psilocybin DepressionPTSDAddiction Randomized Controlled Trial More
